NTSR1 and neoplasm: [55Co]Co-NT-CB-NOTA revealed high tumor uptake, high tumor-to-background contrast, and sustained tumor uptake in HT29 tumor models leading the authors to conclude that NT-Sarcage labeled with 55Co/58mCo may be an excellent theranostic pair targeting NTSR-1 positive cancers (40).